Terms: = Ovarian cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Prognosis
12 results:
1. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA CASC15, MiR-23b Cluster and smad3 form a Novel Positive Feedback Loop to promote Epithelial-Mesenchymal Transition and Metastasis in ovarian cancer.
Lin H; Xu X; Chen K; Fu Z; Wang S; Chen Y; Zhang H; Niu Y; Chen H; Yu H; Shao JZ; Lu W; Wu Y; Xia D
Int J Biol Sci; 2022; 18(5):1989-2002. PubMed ID: 35342355
[TBL] [Abstract] [Full Text] [Related]
3. Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis.
Kitami K; Yoshihara M; Tamauchi S; Sugiyama M; Koya Y; Yamakita Y; Fujimoto H; Iyoshi S; Uno K; Mogi K; Ikeda Y; Yokoi A; Yoshikawa N; Nishino K; Niimi K; Nawa A; Enomoto A; Kajiyama H
Matrix Biol; 2022 May; 109():70-90. PubMed ID: 35339636
[TBL] [Abstract] [Full Text] [Related]
4. Nucleosome Assembly Protein 1-Like 3 Enhances Cisplatin Resistance of ovarian cancer Cell by Activating Transforming Growth Factor-Beta Pathway.
Mo X; Sun J; Xu L; Zhao N; Yan M; Li H; Qin P
J Interferon Cytokine Res; 2020 Jul; 40(7):333-340. PubMed ID: 32701410
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/smad3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract] [Full Text] [Related]
6. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
[TBL] [Abstract] [Full Text] [Related]
7. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.
Peng J; Yoshioka Y; Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Kharma B; Murakami R; Abiko K; Murphy SK; Konishi I
Mol Carcinog; 2016 Apr; 55(4):335-45. PubMed ID: 25663289
[TBL] [Abstract] [Full Text] [Related]
8. Adult granulosa cell tumours of the ovary.
Mancari R; Portuesi R; Colombo N
Curr Opin Oncol; 2014 Sep; 26(5):536-41. PubMed ID: 25024052
[TBL] [Abstract] [Full Text] [Related]
9. WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
Aldaz CM; Ferguson BW; Abba MC
Biochim Biophys Acta; 2014 Aug; 1846(1):188-200. PubMed ID: 24932569
[TBL] [Abstract] [Full Text] [Related]
10. FOXL2, GATA4, and smad3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract] [Full Text] [Related]
11. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
Cheng JC; Auersperg N; Leung PC
PLoS One; 2012; 7(8):e42436. PubMed ID: 22905131
[TBL] [Abstract] [Full Text] [Related]
12. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
Ouellet V; Guyot MC; Le Page C; Filali-Mouhim A; Lussier C; Tonin PN; Provencher DM; Mes-Masson AM
Int J Cancer; 2006 Aug; 119(3):599-607. PubMed ID: 16572426
[TBL] [Abstract] [Full Text] [Related]
